Registration and Real-Life Studies on Automated Insulin Delivery Systems
Authors' conclusion
In this review, we summarize the registration and real-life studies of US Food and Drug Administration (FDA)-approved AID systems. Real-life studies confirmed the glycemic outcomes of AID systems reported from registration studies.
Study context
- Population
- Patients with T1D using automated insulin delivery (AID) systems; registration and real-life studies with the longest duration and/or the largest number of participants
- Outcome
- Glycemic metrics and quality of life with AID systems
Methodological detailssystematic literature search (MEDLINE/PubMed)
- Systematic literature search (MEDLINE/PubMed)
Main finding
As reported in the abstract
- AID systems improved glycemic metrics (HbA1c, time in range (TIR), time below range (TBR)) and quality of life in T1D
- Most registration and real-life studies showed safe and effective AID use for all age groups with T1D
Original publication
Registration and Real-Life Studies on Automated Insulin Delivery Systems. J Diabetes Sci Technol. Published 1 July 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →